Spontaneous abortion is an involuntary interruption of pregnancy before 22 weeks of gestation. According to the Algerian National Institute of Public Health the percentage of women suffering from permanent complications during pregnancy is approximately 15%. The aim of this study is the determination of some biochemical analytes, including folic acid, vitamin B12, alphafoetoproteine, beta human chorionic gonadotropin (β-hCG), progesterone and oestradiol (uE3), which are involved in the detection of pregnancy failures. This case-control study was carried out on women in the process of abortion and a control group with viable pregnancies in the East region of Algeria (Batna) during the year 2015. In the present investigation, 69 pregnant women during the first and second trimester were recruited during the first and second trimesters as cases (with miscarriages) and the control group (n=69) was constituted of women who had normal ultrasound. The average concentration of alpha-fetoprotein is significantly low during the first trimester, but it is very high during the second trimester between cases and controls. The median values of β-hCG, uE3 and progesterone decrease very significantly. The mean concentration of serum folate and vitamin B12 did not change significantly between cases and controls in the first and second trimesters. The results of this study revealed that, spontaneous abortions are associated with changes in serum markers and progesterone, which could form an important part in the early diagnosis of non-viable pregnancies. However, vitamins levels have no significant effects on these pregnancies.
Introduction
Abortion is one of the main complications affecting women at the beginning of pregnancy, leading to the interruption and the expulsion of an embryo or fetus before 22 weeks of amenorrhea. 1 There is no systematic diagnosis, but antenatal screening based on the determination of some biological parameters (vitamins, progesterone and serum markers) seems to be interesting in order to identify high-risk pregnancies and participates in the diagnosis of fetal malformations pathologies. Indeed, vitamins are important micronutrients to stimulate the growth and metabolism of the human beings. Some are essential for the synthesis of nucleic acids that are necessary for any cell division, for the formation of body tissues, while others are essential for energy metabolism and gene transcription. 2 A great increase in vitamin B requirements is observed in the start of pregnancy, especially vitamin B12 (cobalamin) and B9 (folate). 3 Cabrol et al. 4 reporting that one-third of pregnant women have decreased levels of erythrocyte folate during the beginning of pregnancy, this deficiency may be responsible for the anomalies of neural tube closure after conception. From this effect most vitamins can be limiting factors of fetal growth. 4 In addition, serum markers are biochemical molecules, of fetal or placental origin secreted in maternal serum during pregnancy (Pregnancy associated-plasma protein-A (PAPP-A) and free 5 Alpha-fetoprotein and oestriol). These markers are different from one patient to others depending on the number of weeks of amenorrhea and the status of pregnancy. Several studies have demonstrated the importance of these parameters in the diagnosis of fetal abnormalities and malformations pathologies. 6 Thus, progesterone is a steroid that plays an important role in the establishment of pregnancy. It prepares and maintains the endometrium which will allow the implantation and remove the maternal immune response. 7 In this context, we are interested in the measurement of the following parameters: folate, vitamin B12, β-HCG, alphafoetoproteine (AFP), oestradiol and progesterone with a retrospective manner, of hospitalized patients during the first and the second trimesters suffering from complication of pregnancy in order to determine if these parameters contribute really to the establishment of an early diagnosis of non-progressive pathologic pregnancies.
Materials and Methods
A retrospective study was carried out during the year 2015 on patients hospitalized Obstetrics Gynecology Service of the Hospital of Meriem Bouatoura, Batna, Algeria. The entire selected patients are bleeding at the first or the second trimester of pregnancy.
Participation consent of women was obtained and agreed to collaborate in the study, which was approved by the ethics committee of each participating hospital (Obstetrics Gynecology Service of the Hospital of Meriem Bouatoura and the laboratory of Biochemistry, Hospital of Batna, Algeria). The inclusion criteria for this study were a single non-progressive pregnancy that resulted in cessation, miscarriage or fetal death before 24 weeks.
Patients were identified through survey including: family history, age, date and place of birth, as well as gynecological and obstetric given to the mother (parity and pregnancy outcomes, premature birth and eventual abortions and death in utero). Any previous congenital malformations have been recorded.
The sample included 138 pregnant women, 69 of whom were hospitalized for the first trimester (n=39) and the second one (n=30) pregnancy complications, and a control group of 69 women, with normal and progressive pregnancy.
Vitamins (B9, B12), progesterone and serum markers (AFP, β-HCG, uE3) are assayed in maternal blood and expressed in MoM (multiple of the median) for each gestational age. Analysis of these parameters was carried out by the immunoassay system (Elecsys 2010 and cobas e 6000) (Roche Diagnostics, Penzberg, Germany).
Data analysis
Data were analyzed using the one way of variance (ANOVA) a multiple comparison based on a completely random design. P˂0.05 were considered statistically significant. Tukey test was applied to determine exactly which treatments were different (P<0.05). All statistical studies were performed using SPSS Version 20-32bit.
Results
The analyses of demographic, obstetric and clinical data of all the pregnant women studied (138) are not statistically significant and the results are represented in Table 1 .
The serum levels of AFP, β-HCG, uE3, progesterone and vitamins (B9 and B12) are dosed in the first two trimesters for both groups' patients (cases and controls) and the results are shown in Tables 2-4 .
The serum level of alpha-fetoprotein during the first and the second trimesters was (0.762±0.431) vs (2.822±3.293) MoM respectively (P<0.05). Compared to the control group, themean concentration of alpha-fetoprotein is significantly low during the first trimester, but it became very high during the second trimester.
In addition, the median values of β-HCG, EU3, progesterone during the first and the second trimester are respectively: (0.047±0.071 and 0.181±0. (Table 4) .
Discussion
Several studies have suggested that fluctuations in serum markers and vitamins could affect fetal development and outcome of pregnancy. 8 Indeed, our results showed that during the first and the second trimesters, a low rate of β-HCG which is observed in patients during abortion. It is very important to indicate that these results are in good agreement with the previous studies of Dugoff et al. and Rissanen et al. 9 ,10 reporting obviously a low HCG level associated to an increased incidence of spontaneous miscarriage and that extremely low levels of HCG increased the risk of losing pregnancy before 24 weeks.
The same results were previously by Yaron et al. 11 who reported in their study that an increased risk of spontaneous miscarriage is related to a low concentration of free β-HCG. According to Gordon et al., 7 placental dysfunction resulting from an angiogenesis defect induces a perturbation of β-HCG secretion, which plays a major role in stimulating maternal and fetal steroidogenesis and maintaining corpus luteum. This ensures a good evolution of pregnancy until the seventh week. From the 7th to the 10th week of pregnancy the steroidogenesis of the corpus luteum is replaced by the placenta.
The significant decrease of steroid levels reported in our study, is in accordance with data of Bick et al. 12 who have correlated the decrease in uE3 with chromosomal abnormalities, anencephalies and fetal death. 12, 13 In most of these pathologies, the level of estriol is reported as being undetectable (<0.2 MoM). However, our results showed abnormally low serum progesterone levels in abortion patients during the two trimesters, which is in agreement with the results of Weissgerber et al. 14 indicating especially a marked decrease in progesterone. The extrinsic progesterone administration does not extend the gestation period which explains the early onset resulting from abortion. So, progesterone is a good diagnostic marker of non-viable pregnancies as it is the only hormone to maintain the uterine calm. 15, 16 Also a low serum AFP was observed in patients with an abortion in the first trimester. Our results are consistent with several investigations 17, 18 showing the correlation between the low levels of AFP and the spontaneous abortions and the presence of chromosomal abnormalities (aneuploid) such as trisomies and especially when combined with a low levels of HCG. 18 During the second trimester, a significant increase in AFP was observed for affected women compared to the controls. This result is consistent with the literature data, which associate the high abnormal levels of maternal AFP with fetal loss, perinatal death, neonatal deaths, hydrocephalus, diaphragmatic hernias, turner's syndrome, choroid plexus cyst, duodermal atresia, renal pyelectasia and fetal growth restriction. However, moderate increases in AFP levels above the normal value were observed during normal pregnancy in the patient with severe fetoplacental dysfunction explained previously with β-HCG. The placental damage allows a rapid diffusion of the AFP from the fetoplacental compartment to the maternal compartment, thus inducing an increase in the serum AFP level. Indeed, several studies associate the significant increase in AFP with the risk of pre-eclampsia, intrauterine growth retardation (IUGR), retroplacental hematoma with histologic lesions of type thrombotic and inflammatory placental vessels and death in utero (MIU). 19, 20 Serum concentrations of folic acid and vitamin B12 showed a small decrease in the serum of affected patients. This is in agreement with the results of Hoffman et al. 21 reporting that low levels of folate did not appear to be associated with complicated pregnancies at risk of abortion in the first or second trimesters. 
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Conclusions
The aim of the present study is to find how we can detect early prevent pathological pregnancies by the determination of some biochemical parameters in the maternal blood such as folic acid, alphafetoprotein (AFP), Β-HCG, progesterone and oestradiol. This may be an advance in obstetric and neonatal practices because of the high incidence of these complications. Our results show clearly that (alphafoetoprotein, β-HCG, progesterone and oestradiol) could be good markers for the early diagnosis of pregnancies in abortion.
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